News
Events
The industry
Association
- Mission & services
- Members
- Academy
- Insight Events
- Partners
- Team
- Media

Log in or Register

0

Search results

All

Companies

Events

News

Jobs

prev

next

Filters Filters

Filters Filters

Filters Filters

Filters Filters

Filters Filters

Search results

Filters
Categories

Filters
Categories

Filters
Categories

{{label}}

{{label}}

{{displayValue}}

{{label}}

{{label}}

{{label}}

{{locationDetails}}

Search Reset Filters

{{label}}

{{label}}

{{label}}

{{label}}

{{displayValue}}

{{label}}

{{label}}

{{choice.label}}

{{label}}

{{locationDetails}}

Search Reset Filters

{{label}}

{{ range.label }} {{l10n.pick}}

{{label}} {{label}}

{{label}}

{{label}}

{{displayValue}}

{{label}}

{{choice.label}}

{{label}}

{{locationDetails}}

Search Reset Filters

{{label}}

{{label}}

{{label}}

{{choice.label}}

{{label}}

{{displayValue}}

{{label}}

{{locationDetails}}

Search Reset Filters

{{label}}

{{label}}

{{displayValue}}

{{label}}

{{label}}

{{locationDetails}}

Search Reset Filters

{{label}}

{{locationDetails}}

{{label}}

{{locationDetails}}

{{label}}

{{locationDetails}}

{{label}}

{{locationDetails}}

{{label}}

{{locationDetails}}

Back to filters

Browse sub-categories

{{ term.name }}

Add job listing… How to add jobs (members) How to add jobs (non-members)

Subscribe to our newsletter… About the directory

Map view

Adularia AG

R&D

Featured

Member

8006 Zürich

We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.

Therapeutics/vaccines (human)

Bookmark

There are no listings matching your search. Reset Filters

Compare items ({{ compare.length }}) Cancel

Search as I move the map

List view
Map view

Cart

This site uses cookies: Find out more.